These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2858830

  • 1. Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs.
    Hefti F, Enz A, Melamed E.
    Neuropharmacology; 1985 Jan; 24(1):19-23. PubMed ID: 2858830
    [Abstract] [Full Text] [Related]

  • 2. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr M.
    J Neural Transm Park Dis Dement Sect; 1990 Jan; 2(1):15-22. PubMed ID: 2113388
    [Abstract] [Full Text] [Related]

  • 3. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK.
    Brain Res; 1988 Oct 04; 461(2):335-42. PubMed ID: 3141002
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A.
    J Neurochem; 1989 Apr 04; 52(4):1170-82. PubMed ID: 2564423
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW, Slimovitch C, Toffano G.
    Br J Pharmacol; 1990 Apr 04; 99(4):741-9. PubMed ID: 2361171
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism.
    Richard MG, Bennett JP.
    Exp Neurol; 1994 Sep 04; 129(1):57-63. PubMed ID: 7925842
    [Abstract] [Full Text] [Related]

  • 10. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E, Hefti F, Wurtman RJ.
    Isr J Med Sci; 1982 Jan 04; 18(1):159-63. PubMed ID: 6121770
    [Abstract] [Full Text] [Related]

  • 11. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones.
    Parker GC, Rugg EL, Winn P.
    Exp Brain Res; 1991 Jan 04; 87(3):597-603. PubMed ID: 1723691
    [Abstract] [Full Text] [Related]

  • 12. Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?
    Jaffer A, van der Spuy GD, Russell VA, Mintz M, Taljaard JJ.
    Neurodegeneration; 1995 Jun 04; 4(2):139-45. PubMed ID: 7583677
    [Abstract] [Full Text] [Related]

  • 13. Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-dopa.
    Brannan T, Knott P, Kaufmann H, Leung L, Yahr M.
    J Neural Transm; 1989 Jun 04; 75(2):149-57. PubMed ID: 2918307
    [Abstract] [Full Text] [Related]

  • 14. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E, Hefti F, Wurtman RJ.
    Proc Natl Acad Sci U S A; 1980 Jul 04; 77(7):4305-9. PubMed ID: 6254020
    [Abstract] [Full Text] [Related]

  • 15. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec 04; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 16. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis.
    Zetterström T, Brundin P, Gage FH, Sharp T, Isacson O, Dunnett SB, Ungerstedt U, Björklund A.
    Brain Res; 1986 Jan 08; 362(2):344-9. PubMed ID: 2417666
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 Jan 08; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 18. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E, Durst R, Frucht Y, Globus M.
    Eur J Pharmacol; 1983 May 06; 89(3-4):279-82. PubMed ID: 6873163
    [Abstract] [Full Text] [Related]

  • 19. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats.
    Altar CA, O'Neil S, Marshall JF.
    Neuropharmacology; 1984 Mar 06; 23(3):309-18. PubMed ID: 6427648
    [Abstract] [Full Text] [Related]

  • 20. A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine.
    Wong PT, Teo WL, Lee T.
    Neuroreport; 1993 Oct 25; 5(1):53-6. PubMed ID: 7506588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.